Get started
Author

Luke Lajmi

Observed name: L. Lajmi
Observed institution: University of South Florida
OpenAlex ID: A5016700630
14-3-3 and Smad2/3 are crucial mediators of atypical-PKCs: Implications for neuroblastoma progression
2023 · S. Breedy, W.S. Ratnayake, et al. · Frontiers in Oncology · 4
PDF
Abstract 150: Prevalent PKC-ι/ζ signaling is crucial for apoptosis inhibition and invasiveness of glioblastoma through upregulation of Pdk1/Akt1/14-3-3 cascade and Smad2/3
2022 · Wishrawana Sarathi Ratnayake, Khandker M. Khalid, et al. · Cancer Research · 1
Abstract 7151: Targeted inhibition of atypical PKC isoforms PKC-ι and PKC-ζ by ICA-1S and ζ-Stat suppresses oncogenic signaling and cytokine-mediated bone metastasis in prostate cancer
2026 · Wishrawana Sarathi Ratnayake, Grazielly Teodoro, et al. · Cancer Research
Abstract 197: Effects of three nucleoside reverse transcriptase inhibitor analogs on Stat3, NFκB, and JNK/c-Jun signaling in bone metastatic prostate cancer
2025 · Wishrawana Sarathi Ratnayake, Luke Lajmi, et al. · Cancer Research
Abstract 4382: PKC-ι/ζ signaling is crucial for apoptosis/pyroptosis inhibition and invasiveness of glioblastoma cells through upregulation of β-catenin, PDK1/Akt1 and Smad cascades via 14-3-3
2024 · Luke Lajmi, Wishrawana S. Ratnayake, et al. · Cancer Research
Abstract 2032: Osteoblasts alter their protein expression profile in the presence of prostate cancer cells to facilitate their invasion
2024 · Aaron J. Todman, Wishrawana S. Ratnayake, et al. · Cancer Research
Abstract 1672: PKC-ι and 14-3-3 are crucial regulators of c-Raf and the Erk pathway in human medulloblastoma
2024 · Luke Lajmi, Wishrawana S. Ratnayake, et al. · Cancer Research
Abstract 2555: 14-3-3 and Smad2/3 are key mediators of atypical-PKCs in neuroblastoma progression
2023 · Sloan Breedy, Wishrawana S. Ratnayake, et al. · Cancer Research
Abstract 344: PKC-ι is a simultaneous modulator of the sonic hedgehog and the FAK/paxillin pathways in medulloblastoma
2023 · Luke Lajmi, Sloan Breedy, et al. · Cancer Research
Abstract 3609: Interaction of interleukin-6/8/18 with prostate cancer cell secreted growth factors are crucial for osteoblast proliferation and differentiation
2023 · Aaron Jeshua Todman, Wishrawana S. Ratnayake, et al. · Cancer Research
Abstract 158: A combination therapy of atypical protein kinase C inhibitors and phosphatidylinositol-3-kinase inhibitor reduces resistance & invasiveness in renal cell carcinoma (RCC)
2022 · Khandker Mohammad Khalid, Wishrawana S. Ratnayake, et al. · Cancer Research
Abstract 172: Limiting medulloblastoma progression by hindering the Hedgehog signaling pathway with novel atypical protein kinase C inhibitors
2022 · Luke Lajmi, Sloan Breedy, et al. · Cancer Research
Works count: 13
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type